SLN - Silence Therapeutics plc News

Sectors

SLN

Silence Therapeutics plc

10.69

1 x 10.62

10 x 10.74

bid

ask

0.16

1.51%

10:04 AM

timesize

Ytd	75.76%
1y	70.98%

10.74

day range

10.90

4.19

52 week range

11.19

Open	10.75	Prev Close	10.85	Low	10.74	High	10.90	Mkt Cap	512.49M
Vol	32.67K	Avg Vol	388.92K	EPS	-1.56	P/E	-6.96	Forward P/E	N/A
Beta	1.38	Short Ratio	2.36	Inst. Own	62.77%	Dividend	N/A	Div Yield	N/A
Ex Div Date	N/A	Earning	08-06	50-d Avg	7.99	200-d Avg	6.60	1yr Est	53.70

SLN News

zacks.com

SLN Stock Skyrockets 107% in Six Months: Here's What You Need to Know

Silence Therapeutics shares surge as investors eye key 2026 divesiran data, an advancing RNAi pipeli

zacks.com

Silence Therapeutics (SLN) Moves 7.2% Higher: Will This Strength Last?

Silence Therapeutics (SLN) was a big mover last session on higher-than-average trading volume. The l

seekingalpha.com

Silence Therapeutics: PV Data Could Wake The Stock (Initiating Buy)

I initiate Silence Therapeutics at a speculative Buy, driven by near-term divesiran/SLN124 catalysts

zacks.com

Silence Therapeutics (SLN) Surges 26.0%: Is This an Indication of Further Gains?

Silence Therapeutics (SLN) saw its shares surge in the last session with trading volume being higher

benzinga.com

This $300 Million Biotech May Be Deeply Mispriced: Analyst

Silence Therapeutics Plc (NASDAQ:SLN) stock rose Wednesday after Cantor Fitzgerald initiated coverag

benzinga.com

This $300 Million Biotech May Be Deeply Mispriced: Analyst

Silence Therapeutics ($SLN) stock surges as Cantor predicts key August Phase 2 data will be a major

benzinga.com

Cantor Fitzgerald Initiates Coverage On Silence Therapeutics with Overweight Rating

Cantor Fitzgerald analyst Prakhar Agrawal initiates coverage on Silence Therapeutics (NASDAQ:SLN)

benzinga.com

Sophia Genetics, Ormat Technologies And Other Big Stocks Moving Lower In Wednesday's Pre-Market Sess

U.S. stock futures mostly higher, Nasdaq futures gain 100+ points. Sophia Genetics (SOPH) falls afte

benzinga.com

Silence Therapeutics Stock Rises On Positive Blood Cancer Drug Data

Silence Therapeutics Plc (NASDAQ:SLN) shares are up during Friday's session. On Thursday, the compan

benzinga.com

Silence Therapeutics Stock Rises On Positive Blood Cancer Drug Data

Silence Therapeutics says SANRECO data show sustained polycythemia vera benefits as analysts weigh d

gurufocus.com

Silence Therapeutics Highlights Follow-Up Data at EHA 2026 Demonstrating Durable Efficacy and Potent

Silence Therapeutics plc (Nasdaq: SLN), a global clinical-stage biotechnology company developing nov

businesswire.com

Silence Therapeutics Highlights Follow-Up Data at EHA 2026 Demonstrating Durable Efficacy and Potent

LONDON--(BUSINESS WIRE)---- $SLN #SenseofSilence--Silence Therapeutics plc (Nasdaq: SLN), a global c

businesswire.com

Silence Therapeutics to Participate in Jefferies Global Healthcare Conference

LONDON--(BUSINESS WIRE)---- $SLN #SenseofSilence--Silence Therapeutics plc (Nasdaq: SLN), a global c

businesswire.com

Silence Therapeutics to Participate in H.C. Wainwright BioConnect Investor Conference

LONDON--(BUSINESS WIRE)---- $SLN #SenseofSilence--Silence Therapeutics plc (Nasdaq: SLN), a global c

businesswire.com

Silence Therapeutics Highlights Recent Business Achievements and Reports First Quarter 2026 Financia

LONDON--(BUSINESS WIRE)---- $SLN #SenseofSilence--Silence Therapeutics plc, Nasdaq: SLN (“Silence” o

zacks.com

Silence Therapeutics (SLN) Soars 19.0%: Is Further Upside Left in the Stock?

Silence Therapeutics (SLN) saw its shares surge in the last session with trading volume being higher

defenseworld.net

Silence Therapeutics PLC Sponsored ADR (NASDAQ:SLN) Given Average Recommendation of “Moderate Buy” b

Shares of Silence Therapeutics PLC Sponsored ADR (NASDAQ: SLN - Get Free Report) have received an av

benzinga.com

Why Urgent.ly Shares Are Trading Higher By Around 159%; Here Are 20 Stocks Moving Premarket

Urgent.ly shares surged in pre-market trading after agreement to be acquired by Agero for $5.50 per

defenseworld.net

Silence Therapeutics (NASDAQ:SLN) versus Avalo Therapeutics (NASDAQ:AVTX) Head-To-Head Comparison

Avalo Therapeutics (NASDAQ: AVTX - Get Free Report) and Silence Therapeutics (NASDAQ: SLN - Get Free

zacks.com

Wall Street Analysts See a 467.47% Upside in Silence Therapeutics (SLN): Can the Stock Really Move T

The consensus price target hints at a 467.5% upside potential for Silence Therapeutics (SLN). While

businesswire.com

Silence Therapeutics Highlights Recent Business Achievements and Reports Fourth Quarter and Full Yea

LONDON--(BUSINESS WIRE)---- $SLN #SenseofSilence--Silence Therapeutics plc, Nasdaq: SLN, a global cl

benzinga.com

12 Health Care Stocks Moving In Monday's Pre-Market Session

defenseworld.net

Silence Therapeutics PLC Sponsored ADR (NASDAQ:SLN) Receives Consensus Recommendation of “Hold” from

Silence Therapeutics PLC Sponsored ADR (NASDAQ: SLN - Get Free Report) has earned a consensus recomm

businesswire.com

Silence Therapeutics Announces Leadership Changes

LONDON--(BUSINESS WIRE)---- $SLN #SenseofSilence--Silence Therapeutics plc, Nasdaq: SLN (“Silence” o

seekingalpha.com

Silence Therapeutics: Divesiran Targets High-Burden PV

Silence Therapeutics is advancing its lead RNAi drug, divesiran, for polycythemia vera, with a fully

businesswire.com

Silence Therapeutics Reports Third Quarter 2025 Financial Results and Recent Business Highlights

LONDON--(BUSINESS WIRE)---- $SLN #SenseofSilence--Silence Therapeutics plc, Nasdaq: SLN (“Silence” o

benzinga.com

Earnings Scheduled For February 27, 2025

benzinga.com

Earnings Scheduled For March 12, 2024

Companies Reporting Before The Bell • Aurora Mobile (NASDAQ:JG) is likely to report earnings for it

benzinga.com

Stocks That Hit 52-Week Lows On Friday

On Friday, 1043 companies hit new 52-week lows.